Amgen Inc. Agrees to Purchase Dublin-based Horizon Therapeutics Plc. for €24.7 Billion
Amgen Inc. has agreed to buy Dublin-based Horizon Therapeutics Plc. for €24.7 billion ($26 billion), in a deal that could face further delays or a breakdown in negotiations. Following Sanofi's withdrawal from the race, citing "transaction price expectations that do not meet [their] value creation criteria" - for the purposes of Rule 2.12 of the Irish Takeover Rules in response to Horizon's announcement under Rule 2.4 of the Irish Takeover Rules - Amgen has confirmed that any offer is, or is likely to be, solely in cash. If Amgen buys Horizon, it will be the largest acquisit...
